SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-148728
Filing Date
2016-11-07
Accepted
2016-11-07 18:51:28
Documents
2
Period of Report
2016-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4142
2 POA DOCUMENT poa.txt EX-24.3_682712 3054
  Complete submission text file 0001209191-16-148728.txt   8676
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Issuer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address
Happel David (Reporting) CIK: 0001623567 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35238 | Film No.: 161979556